Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children’s Oncology Group

PURPOSE: Survivors of childhood acute lymphoblastic leukemia (ALL) are at risk for neurocognitive deficits that are associated with treatment, individual, and environmental factors. This study examined the impact of different methotrexate (MTX) and corticosteroid treatment strategies on neurocogniti...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Oncol
Auteurs principaux: Hardy, Kristina K., Embry, Leanne, Kairalla, John A., Helian, Shanjun, Devidas, Meenakshi, Armstrong, Daniel, Hunger, Stephen, Carroll, William L., Larsen, Eric, Raetz, Elizabeth A., Loh, Mignon L., Yang, Wenjian, Relling, Mary V., Noll, Robert B., Winick, Naomi
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2017
Sujets:
ORIGINAL REPORTS
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5549456/
https://ncbi.nlm.nih.gov/pubmed/28671857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.71.7587
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires